Neptune Technologies & Bioressources Inc. ~ Onemia

LAVAL, QuebecNeptune Technologies & Bioressources Inc. introduced Onemia, a pharmaceutical marine-based omega-3 phospholipid concentrate classified as a novel medical food, regulated by FDA and shown to be safe and effective for the management of unmet medical needs associated with  chronic cardiometabolic disorders. Onemia is formulated in a hard gelatin capsule to be taken alone or in combination with currently approved and prescribed cardiovascular drugs administered only under physician supervision and dispensed by medical recommendation and, in some cases, by prescription, in compliance with applicable FDA standards. Onemia will be manufactured by Neptune and sold to Acasti, Neptunes subsidiary.